Business
Result of 2025 AGM
Result of 2025 AGM.
About this update from Dr. Martens Plc
10 July 2025 DR. MARTENS PLC RESULT OF ANNUAL GENERAL MEETING 10 JULY 2025 The Company announces the results of voting at its Annual General Meeting held earlier today and confirms that all resolutions were duly passed on a poll with majorities as set out below. Resolutions 1 to 18 were proposed as Ordinary Resolutions and resolutions 19 to 22 as Special Resolutions. Resolution Votes For (note 1) % Votes Against (note 1) % Votes Total Votes Withheld (note 2) % Voting Capital Instructed 01 Receive the 2025 Annual Report and Accounts 786,076,243 100.00 34,102 0.00 786,110,345 370,385 81.35% 02 Approve the Directors' Remuneration Report 782,786,026 99.59 3,213,373 0.41 785,999,399 475,436 81.34% 03 Approve the Final Dividend 786,441,111 100.00 32,729 0.00 786,473,840 6,890 81.39% 04 Elect Ije Nwokorie 711,638,324 90.49 74,812,462 9.51 786,450,786 24,049 81.38% 05 Elect Benoit Vauchy 710,606,698 90.36 75,837,289 9.64 786,443,987 30,848 81.38% 06 Elect Robert Hanson 786,302,310 99.98 134,818 0.02 786,437,128 37,707 81.38% 07 Re-elect Giles Wilson 711,569,954 90.49 74,821,751 9.51 786,391,705 83,130 81.38% 08 Re-elect Lynne Weedall 777,807,755 98.90 8,621,954 1.10 786,429,709 45,126 81.38% 09 Re-elect Robyn Perriss 782,666,553 99.52 3,762,111 0.48 786,428,664 46,171 81.38% 10 Re-elect Andrew Harrison 782,674,150 99.52 3,768,078 0.48 786,442,228 32,607 81.38% 11 Re-elect Ian Rogers 781,923,703 99.43 4,518,525 0.57 786,442,228 32,607 81.38% 12 Re-elect Paul Mason 659,171,361 88.07 89,279,024 11.93 748,450,385 38,024,450 77.45% 13 Re-elect Tara Alhadeff 700,151,020 89.26 84,277,826 10.74 784,428,846 2,045,989 81.18% 14 Re-appoint PricewaterhouseCoopers LLP as auditor 786,339,031 99.99 54,271 0.01 786,393,302 81,533 81.38% 15 Authorise the Audit & Risk Committee to determine the Auditor's remuneration 786,364,884 99.99 43,453 0.01 786,408,337 66,498 81.38% 16 Approve the removal of the 5% dilution limit for discretionary share plans 785,386,811 99.87 1,055,301 0.13 786,442,112 38,618 81.38% 17 Authorise the Company and its subsidiaries to make political donations 785,724,771 99.92 665,753 0.08 786,390,524 90,206 81.38% 18 Authorise allotment of shares 783,312,171 99.62 2,997,814 0.38 786,309,985 170,745 81.37% 19 Authorise general disapplication of pre-emption rights* 745,894,239 94.86 40,453,577 5.14 786,347,816 127,019 81.37% 20 Authorise additional disapplication of pre-emption rights* 745,011,084 94.74 41,380,015 5.26 786,391,099 83,736 81.38% 21 Authorise purchase of own shares* 771,750,586 98.19 14,255,925 1.81 786,006,511 474,219 81.34% 22 Authorise calling of general meetings on 14 days' notice* 782,554,288 99.51 3,857,228 0.49 786,411,516 63,319 81.38% *Special Resolution The votes of independent shareholders on the resolutions concerning the election or re-election of the Independent Non-Executive Directors are set out below: Resolution Votes For % Votes Against % Votes Total Votes Withheld % Independent Capital Instructed 06 Elect Robert Hanson 416,359,870 99.97 134,818 0.03 416,494,688 37,707 69.83% 08 Re-elect Lynne Weedall 407,865,315 97.93 8,621,954 2.07 416,487,269 45,126 69.83% 09 Re-elect Robyn Perriss 412,724,113 99.10 3,762,111 0.90 416,486,224 46,171 69.83% 10 Re-elect Andrew Harrison 412,731,710 99.10 3,768,078 0.90 416,499,788 32,607 69.84% 11 Re-elect Ian Rogers 411,981,263 98.92 4,518,525 1.08 416,499,788 32,607 69.84% Notes: 1. Votes "For" and "Against" are expressed as a percentage of votes received. 2. A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution. 3. As at 6.30pm on 9 July 2025 the Company had a total of 966,341,901 ordinary shares with voting rights in issue. The total independent voting capital, used to calculate the votes of independent shareholders on resolutions 6 and 8 to 11, was 596,399,461 . 4. In accordance with Listing Rule 6.4.2(R), copies of the resolutions passed as special business will shortly be available for inspection on the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism . Enquiries Company Secretariat Paul Rolling, Head of Secretariat +44 7584 243562 Investors and analysts Bethany Barnes, Director of Investor Relations +44 7825 187465 [email protected] Beth Fionda, Investor Relations Manager [email protected] Press Sodali & Co Ludo Baynham-Herd Oliver Banks [email protected] +44 207 250 1446 About Dr. Martens Founded in 1960, Dr. Martens is an iconic British brand with a global presence. "Docs" or "DMs" were originally produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history. It operates in over 60 countries and employs over 3,650 people worldwide. Its operations are split across both Direct-to-Consumer and wholesale channels, and in addition to its world-renowned "1460" boot its product segments span shoes including the 1461 shoe and Adrian loafer, sandals including the Zebzag mule, Kids ranges, as well as a growing line of bags and accessories. Further information can be found at https://www.drmartensplc.com/